1 year return (CAGR)
250.34%
Opus Genetics, Inc. Exchange (NASDAQ, USD)
IRD
5.22
+0.04 (+0.77%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
9.10%
5 year return (CAGR)
2.47%
10 year return (CAGR)
-26.91%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
434.28M
Price/Sales
44.06
Ent value
451.42M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-56.78%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.17 |
| Daily high | 5.55 |
| Daily low | 5.17 |
| Daily Volume | 1.98M |
| All-time high | 2880.00 |
| 1y analyst estimate | 10.61 |
| Beta | 0.58 |
| EPS (TTM) | -0.97 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| IRD | S&P500 | |
| Current price drop from All-time high | -99.82% | -0.56% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 11 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -87.60% | -10.68% |
| Avg time to new high | 140 days | 12 days |
| Max time to new high | 4609 days | 1805 days |
News
